YÜKSEL, M. Et Al. 2021. HOW SHOULD WE APPROACH HODGKIN LYMPHOMA (HL) PATIENTS WITH AN EXTRA LYMPHATIC DISEASE (ELD) IN THE ERA OF NOVEL THERAPIES?. pan pacific conference 2021 .

YÜKSEL, M., YAVUZ, G., ÖZTÜRK, C., USLU, A., & KUZU, I., (2021). HOW SHOULD WE APPROACH HODGKIN LYMPHOMA (HL) PATIENTS WITH AN EXTRA LYMPHATIC DISEASE (ELD) IN THE ERA OF NOVEL THERAPIES? . pan pacific conference 2021

YÜKSEL, MELTEM Et Al. "HOW SHOULD WE APPROACH HODGKIN LYMPHOMA (HL) PATIENTS WITH AN EXTRA LYMPHATIC DISEASE (ELD) IN THE ERA OF NOVEL THERAPIES?," pan pacific conference 2021, 2021

YÜKSEL, MELTEM Et Al. "HOW SHOULD WE APPROACH HODGKIN LYMPHOMA (HL) PATIENTS WITH AN EXTRA LYMPHATIC DISEASE (ELD) IN THE ERA OF NOVEL THERAPIES?." pan pacific conference 2021 , 2021

YÜKSEL, M. Et Al. (2021) . "HOW SHOULD WE APPROACH HODGKIN LYMPHOMA (HL) PATIENTS WITH AN EXTRA LYMPHATIC DISEASE (ELD) IN THE ERA OF NOVEL THERAPIES?." pan pacific conference 2021 .

@conferencepaper{conferencepaper, author={MELTEM YÜKSEL Et Al. }, title={HOW SHOULD WE APPROACH HODGKIN LYMPHOMA (HL) PATIENTS WITH AN EXTRA LYMPHATIC DISEASE (ELD) IN THE ERA OF NOVEL THERAPIES?}, congress name={pan pacific conference 2021}, city={}, country={}, year={2021}}